Searching map area
Vandetanib plus pemetrexed for the second-line treatment of advanced non-small-cell lung cancer: a randomized, double-blind phase III trial
? TBD
scientific article published on 31 January 2011
Nobody has rated this yet. Be the first!
Lists 0